Iopromide

碘普胺

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameIopromide
Drug Alias Name碘葡罗氨Tiopronin iodiniopromidum碘普罗胺iopromida +[11] 
ClassificationSmall moleculesDiagnostic agent (In vivo) > Contrast agent
Mechanisms of ActionMuscarinic acetylcholine receptor M1 antagonistsMuscarinic acetylcholine receptor M3 antagonists
TargetsMuscarinic acetylcholine receptor M1Muscarinic acetylcholine receptor M3
Therapy Area/IndicationsContrast agents
Global Approved IndicationsContrast agents
Approved Indications in ChinaContrast agents
Original Approved Country/TerritoryGermany
Original Approved Date1985/02/28
Country/TerritoryCanadaUnited StatesGermany +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesBayer Healthcare Pharmaceuticals IncBayer Medical & Health Co Ltd Guangzhou Branch
Inactive CompaniesN/A
Active IndicationsContrast agents
Inactive IndicationsN/A

Other Information

ATC CodeV08AB05
Related LinksWikipediaDrugBankKEGG